Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract.
Gut flora in health and disease.
Quality of life and satisfaction with outcome among prostate-cancer survivors.
Intestinal mucosal barrier function in health and disease.
The route of enteric infection in normal mice.
Salmonellae interplay with host cells.
Diseases of humans (other than cholera) caused by vibrios.
The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats.
Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal.
Study of infectious intestinal disease in England: rates in the community, presenting to general practice, and reported to national surveillance. The Infectious Intestinal Disease Study Executive.
Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae.
Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application.
Animal models of sepsis: setting the stage.
Myofibroblasts. II. Intestinal subepithelial myofibroblasts.
Electrolyte transport in the mammalian colon: mechanisms and implications for disease.
Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans.
Colonic secretion of water and electrolytes induced by bile acids: perfusion studies in man.
Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease.
Pathogenesis of enteric infection by Campylobacter.
Effect of dietary fibre on stools and the transit-times, and its role in the causation of disease.